Add-on Acquisition • Life Science

Camargo Pharmaceutical Services Acquires Paidion Research

On March 2, 2021, Camargo Pharmaceutical Services acquired life science company Paidion Research

Acquisition Context
  • This is Camargo Pharmaceutical Services’ 2nd transaction in the Life Science sector.
  • This is Camargo Pharmaceutical Services’ 1st transaction in the United States.
  • This is Camargo Pharmaceutical Services’ 1st transaction in North Carolina.

Explore All 3109 Add-on Acquisition Life Science Deals - Search the Database Free


M&A Deal Summary

Date March 2, 2021
Target Paidion Research
Sector Life Science
Buyer(s) Camargo Pharmaceutical Services
Deal Type Add-on Acquisition

Target Company

Paidion Research

Durham, North Carolina, United States
Paidion provides clinical research coordination services that improve the health of children around the world by helping companies and organizations develop clinical trials for pediatric patients. Paidion is dedicated to bringing safe and effective treatments to neonates, infants, children, and adolescents. Paidion Research, Inc. was founded in 2013 and is based in Durham, North Carolina.
Explore More Deals

Browse All 215,156 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

Buyer

Camargo Pharmaceutical Services

Cincinnati, Ohio, United States

Category Company
Founded 2003
Sector Life Science
DESCRIPTION

Camargo Pharmaceutical Services is a global development and commercialization partner to large and small biotech and pharmaceutical companies. Camargo specializes in rare and complex development programs where no playbook exists, with integrated solutions to reach milestones with speed and capital efficiency. Camargo Pharmaceutical Services was founded in 2003 and is based in Cincinnati, Ohio.


Deal Context for Buyer #
Overall 2 of 2
Sector: Life Science 2 of 2
Type: Add-on Acquisition 2 of 2
State: North Carolina 1 of 1
Country: United States 1 of 1
Year: 2021 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-06-13 InSymbiosis

Montreal, Quebec, Canada

InSymbiosis is a drug development partner which improves how biopharma companies outsource R&D. InSymbiosis managed by seasoned ex-pharma and contract research organization drug development scientists and executives. InSymbiosis was founded in 2005 and is based in Montreal, Canada.

Buy -